During treatment, CYP+DOX-treated TB mice exhibited a significantly reduced rate of tumor growth compared to the saline group, highlighting the efficacy of CYP+DOX chemotherapy in controlling tumor progression and indicating that the doses used were appropriate for a CRCI model. The gene discussed is PPIG; the disease is neoplasm.